Paul Goepfert

21PUBLICATIONS
221CO-AUTHORS
Predictive and prognostic markersInnate immunityNutrigenomics and personalised nutritionMedical molecular engineering of nucleic acids and proteinsInfectious diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Nov 04, 2026
Distinct T cell correlates of COVID-19 risk before and after a second booster in previously SARS-CoV-2 infected versus naïve COVAIL trial participants.

|Mar 02, 2026
IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients.

Anoma Nellore, Paul Goepfert, Chen Sabrina Tan

|Feb 28, 2026
IDSA 2025 Guideline on the Use of Vaccines for the Prevention of Seasonal Influenza Infections in Immunocompromised Patients.

Paul Goepfert, Morgan J Katz, Daniel Kaul

|Nov 17, 2025
Long COVID trajectories in the prospectively followed RECOVER-Adult US cohort.

Tanayott Thaweethai, Sarah E Donohue, Jeffrey N Martin

|Jul 30, 2025
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.

K Rachael Parks, Zoe Moodie, Mary A Allen

|Jan 17, 2025
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.

Bo Zhang, Youyi Fong, Lauren Dang

Pageof 4

Frequent Collaborators

7 joint publications

Peter B Gilbert

5 joint publications

Craig A Magaret

5 joint publications

Lawrence Corey

5 joint publications

Lindsay N Carpp